Among patients with COVID-19, compared with those without DM, those with DM had higher levels of inflammation markers, including interleukin-6, C-reactive protein and ferritin, which suggested that the pro-inflammatory state of patients with DM was prone to rapid deterioration and subsequently poor COVID-19 outcomes [8]. The gene discussed is CRP; the disease is COVID-19.